NASDAQ · Financial Statements

Mersana Therapeutics, Inc. (MRSN) Financial Statements

$29.08 NASDAQ: MRSN Market Cap $145.36M

Mersana Therapeutics, Inc. most recently reported annual revenue of $40.0M, net profit of $-69.0M, revenue has compounded at -1.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$1.0M$0$27.0M$37.0M$40.0M
Operating Profit$-155.0M$-169.0M$-204.0M$-171.0M$-73.0M
Net Profit$-88.0M$-170.0M$-204.0M$-172.0M$-69.0M
EPS$-35.80$-60.24$-54.51$-36.96$-14.12
Op Margin-18737.4%-392693.0%-766.6%-463.9%-181.1%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$273.0M$206.0M$334.0M$226.0M$145.0M
Total Liabilities$45.0M$84.0M$242.0M$189.0M$154.0M
Cash$255.0M$178.0M$129.0M$175.0M$108.0M
Borrowings$17.0M$38.0M$36.0M$34.0M$29.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-75.0M$-140.0M$-49.0M$-169.0M$-82.0M
Investing Cash Flow$37.0M$-1.0M$-155.0M$118.0M$11.0M
Financing Cash Flow$4.0M$2.0M$2.0M$1.0M$1.0M
Net Cash Flow$193.0M$-77.0M$-49.0M$46.0M$-67.0M
Free Cash Flow$-75.0M$-141.0M$-52.0M$-171.0M$-82.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.35
EV / EBITDA-1.71
FCF Yield-37.92%
Quick Ratio1.39
Interest Coverage-28.52
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
MRSN Overview MRSN Dividend Run Stock Screener